NEW YORK, October 27, 2022 /PRNewswire/ —
If you own an interest in any of the companies listed above and would like to discuss our investigations or have any questions about this notice or your rights or interests, please contact:
Joshua Rubin, Esq.
white law
305 Broadway, 7th floor
New York, NY 10007
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com
Silverback Therapeutics, Inc. SBTX
Weiss Law is investigating possible breaches of fiduciary duty and other legal violations by the board of directors of Silverback Therapeutics, Inc. SBTX, in connection with SBTX’s proposed merger with ARS Pharmaceuticals, Inc. (“ARS”). Subject to the terms of the Merger Agreement, assuming SBTX’s net cash position at closing $240 million, SBTX shareholders are expected to own only approximately 37% of the combined company, and pre-merger ARS shareholders are expected to own approximately 63% of the combined company. If you own SBTX stock and would like to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/sbtx
Ra Medical Systems, Inc. RMED
Weiss Law is investigating possible breaches of fiduciary duty and other legal violations by the board of directors Ra Medical Systems, Inc. RMED in connection with the Company’s proposed merger with Catheter Precision, Inc. (“Catheter Precision”). The merger is structured as a reverse stock merger, in which all of Catheter Precision’s outstanding convertible debentures and equity interest will be exchanged for RMED common stock and Catheter Precision options acquired by RMED. If you own RMED stock and would like to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/rmed
Renovacor, Inc. RCOR
Weiss Law is investigating possible breaches of fiduciary duty and other legal violations by the board of directors of Renovacor, Inc. RCORin connection with Rocket’s proposed acquisition of RCOR…
